Stock Earnings

Question 1

¿Cuáles son los estados financieros clave de Basilea Pharmaceutica AG Allschwil?

Accepted Answer

Según el último estado financiero (Form-10K), Basilea Pharmaceutica AG Allschwil tiene un total de activos de $257, una ganancia neta profit de $77

Question 2

¿Cuáles son los ratios financieros clave para BPMUF?

Accepted Answer

El ratio corriente de Basilea Pharmaceutica AG Allschwil es 1.46, el margen neto es 37.01, las ventas por acción son $15.01.

Question 3

¿Cómo se desglosan los ingresos de Basilea Pharmaceutica AG Allschwil por segmento o geografía?

Accepted Answer

Basilea Pharmaceutica AG Allschwil largest revenue segment is Innovative Pharmaceutical Products, at a revenue of 208,543,000 in the most earnings release.For geography, Ireland is the primary market for Basilea Pharmaceutica AG Allschwil, at a revenue of 93,700,000.

Question 4

¿Es rentable Basilea Pharmaceutica AG Allschwil?

Accepted Answer

yes, según los últimos estados financieros, Basilea Pharmaceutica AG Allschwil tiene una ganancia neta profit de $77

Question 5

¿Tiene Basilea Pharmaceutica AG Allschwil alguna deuda?

Accepted Answer

yes, Basilea Pharmaceutica AG Allschwil tiene una deuda de 176

Question 6

¿Cuántas acciones en circulación tiene Basilea Pharmaceutica AG Allschwil?

Accepted Answer

Basilea Pharmaceutica AG Allschwil tiene un total de acciones en circulación de 12.08

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	236	208	157	147	148	127
Revenue Growth (YoY)	57.99%	32%	7%	-1%	17%	-5%
Cost of Revenue	44	38	26	24	24	24
Gross Profit	191	169	130	123	124	103
Selling, General & Admin	33	31	33	30	29	29
Research & Development	81	77	77	73	93	97
Operating Expenses	115	108	111	104	122	126
Other Non Operating Income (Expenses)	-1	2	0	3	0	1
Pretax Income	72	60	10	12	-6	-14
Income Tax Expense	0	-17	0	0	0	0
Net Income	72	77	10	12	-6	-14
Net Income Growth	--	670%	-17%	-300%	-56.99%	-36%
Shares Outstanding (Diluted)	13.84	13.85	11.99	11.86	11.68	10.28
Shares Change (YoY)	0%	16%	1%	2%	14%	-4%
EPS (Diluted)	5.23	5.6	0.87	1.02	-0.58	-1.43
EPS Growth	-13,187%	543%	-15%	-275%	-59%	-31%
Free Cash Flow	77	72	13	3	-32	-56
Free Cash Flow Per Share	5.56	5.19	1.08	0.25	-2.73	-5.44
Gross Margin	80.93%	81.25%	82.8%	83.67%	83.78%	81.1%
Operating Margin	31.77%	29.32%	12.1%	12.24%	0.67%	-18.11%
Profit Margin	30.5%	37.01%	6.36%	8.16%	-4.05%	-11.02%
Free Cash Flow Margin	32.62%	34.61%	8.28%	2.04%	-21.62%	-44.09%
EBITDA	76	62	20	19	1	-22
EBITDA Margin	32.2%	29.8%	12.73%	12.92%	0.67%	-17.32%
D&A For EBITDA	1	1	1	1	0	1
EBIT	75	61	19	18	1	-23
EBIT Margin	31.77%	29.32%	12.1%	12.24%	0.67%	-18.11%
Effective Tax Rate	0%	-28.33%	0%	0%	0%	0%

Basilea Pharmaceutica AG Allschwil (BPMUF) Price

BPMUF Stock Price Chart

BPMUF Income

Follow-Up Questions